Related Practice Life Sciences & Pharma Immuno-oncology has significant diagnostic needs including identifying patients most likely to respond to therapies. 08012019170843
Published Articles Life Sciences & Pharma How AI is Defining the Future of Drug Discovery September 5, 2022
Executive Insights Life Sciences & Pharma How the Inflation Reduction Act Will Impact the Biopharmaceutical Industry September 9, 2022
Executive Insights Contract Services L.E.K. Consulting’s Inaugural Clinical and eClinical Pharma Services Survey September 27, 2022
Executive Insights Organization & Performance Setting the Tone — Defining How the IMO Will Guide the Integration June 22, 2022
Article Life Sciences & Pharma Hospital Priorities 2022 (China Edition): Implications for Pharma Companies June 16, 2022
